2025 PACT Philadelphia Venture Report Released
The report highlighted several Penn spinouts.
Featured Startup: Nairon Energy
Nairon Energy is building high-voltage sodium-iron batteries to strengthen grid resilience and support long-duration energy storage.
Ultragenyx Reports Promising Phase III Clinical Trial Results for Urea Cycle Disorder Treatment
Ultragenyx’s gene therapy DTX301, based on technology invented by Jim Wilson, MD, PhD, Emeritus Professor at Penn Medicine, helped control ammonia levels in patients with a urea cycle disorder.
Previous President’s Innovation Prize Winners Recognized in Technical.ly’s RealLIST
Both companies are Penn I-Corps graduates.
Serpent Robotics Wins 2026 President’s Innovation Prize
Serpent Robotics, founded by Wharton undergraduate Margaret Zhu, is developing an electric, rope‑climbing robotic system.
Avisi Technologies Raises $11M to Advance Glaucoma Treatment
The funding will support Avisi’s pivotal clinical trial for VisiPlate, a novel glaucoma treatment. device
Verismo Therapeutics Receives $28 million to Accelerate KIR-CAR Clinical Development
The funding from HLB Innovation, Verismo’s parent company, will advance clinical development of its killer cell immunoglobulin-like receptor (KIR)-chimeric antigen receptor (CAR) platform\.
Biogen to Acquire Apellis for $5.6B
Apellis’ C3 complement therapies, Syfovre® and Empaveli® will expand Biogen's presence in immunology.
Investment Funds available for Penn Startups
Penn has three investment funds available for early stage startups affiliated with the University.
Multiple Penn Affiliated Startups are Finalists for Awards at Life Science PA’s Annual Awards Dinner and Showcase
Each year, Life Sciences PA hosts a celebration to honor the innovation and commitment members have made to the life sciences industry.